Portfolio company
Profluent Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Profluent
This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.
Provolut
This company develops artificial intelligence software for protein and enzyme engineering to support researchers in the pharmaceutical and industrial biotechnology sectors.
Cradle Bio
Cradle provides a generative artificial intelligence platform for engineering proteins to scientists in the pharmaceutical, chemical and agricultural industries.
Anthrogen
This company develops artificial intelligence models and experimental infrastructure to design modular proteins and biological machines for healthcare, industrial and climate applications.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Synteny Biotechnology
The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.
